SCHEMBL17400026

SCHEMBL17400026

COC(=O)c1ccc(CCCc2cc(C)nc(N(Cc3ccc(OC)cc3)Cc3ccc(OC)cc3)n2)c(B2OC(C)(C)C(C)(C)O2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ UCHL1 P09936 1/20 0.41
▸ ALDH1A1 P00352 5/20 0.35
▸ KIF11 P52732 1/20 0.33
▸ PIK3CA P42336 1/20 0.32
▸ MAPT P10636 3/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.31
▸ RAB9A P51151 2/20 0.31
▸ NPC1 O15118 1/20 0.31
▸ TSHR P16473 2/20 0.31
▸ GAA P10253 2/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ CA1 P00915 1/20 0.31
▸ CA2 P00918 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31
▸ LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17400023 0.85 UCHL1 (0.39) UCHL1ALDH1A1KIF11PIK3CAKMT2A
SCHEMBL17386275 0.83 ALDH1A1 (0.39) ALDH1A1PIK3CAMAPTKMT2AKDM4E
SCHEMBL17429702 0.77 CXCR2 (0.35) UCHL1ALDH1A1KMT2AMEN1RAB9A
SCHEMBL17400105 0.77 ALDH1A1 (0.43) ALDH1A1PIK3CAMAPTKMT2AKDM4E
SCHEMBL17418052 0.75 UCHL1 (0.40) UCHL1ALDH1A1MAPTKMT2ACA1
SCHEMBL17400118 0.74 LIPG (0.37) UCHL1ALDH1A1KDM4EL3MBTL1CXCR2
SCHEMBL17385991 0.74 UCHL1 (0.39) UCHL1ALDH1A1KMT2AKDM4ESMN1; SMN2
SCHEMBL17386132 0.74 MTNR1A (0.45) KMT2AMEN1RAB9ACA1CA2
SCHEMBL17429651 0.74 CYP4A11 (0.38) UCHL1ALDH1A1MAPTKMT2AKDM4E
SCHEMBL17385776 0.73 UCHL1 (0.38) UCHL1ALDH1A1KMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9643946-B2 Tricyclic compound and use thereof SK CHEMICALS CO., LTD. (KR) 2017-05-09 — — US disclosed
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF SK CHEMICALS CO., LTD. (KR) 2016-01-14 — — US disclosed
EP-2963027-A1 TRICYCLIC COMPOUND AND USE THEREOF SK Chemicals Co., Ltd. (KR) 2016-01-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160009677-A1 TRICYCLIC COMPOUND AND USE THEREOF GPR65, GPR119, GPR35 UCHL1 4494/4885ALDH1A1 2066/4885KIF11 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback